CH141804A - Process for the preparation of a compound of isopropylallylbarbituric acid with 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. - Google Patents
Process for the preparation of a compound of isopropylallylbarbituric acid with 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone.Info
- Publication number
- CH141804A CH141804A CH141804DA CH141804A CH 141804 A CH141804 A CH 141804A CH 141804D A CH141804D A CH 141804DA CH 141804 A CH141804 A CH 141804A
- Authority
- CH
- Switzerland
- Prior art keywords
- sep
- dimethyl
- phenyl
- acid
- pyrazolone
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 5
- 238000000034 method Methods 0.000 title claims description 4
- UORJNBVJVRLXMQ-UHFFFAOYSA-N aprobarbital Chemical compound C=CCC1(C(C)C)C(=O)NC(=O)NC1=O UORJNBVJVRLXMQ-UHFFFAOYSA-N 0.000 title claims description 3
- 229960003153 aprobarbital Drugs 0.000 title claims description 3
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 title 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 230000000202 analgesic effect Effects 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- YUYFGUSFMDPGGJ-UHFFFAOYSA-N 2-(dimethylamino)-4H-pyrazol-3-one Chemical compound CN(C)N1N=CCC1=O YUYFGUSFMDPGGJ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- -1 methyl- Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical compound O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/26—1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Darstellung einer Verbindung von Isopropylallylbarbitursäure mit 1-Phenyl-2,3-dimethyl-4-dimethylamino-6-pyrazolon.
EMI0001.0003
Es <SEP> wurde <SEP> gefün@d@en, <SEP> :dass' <SEP> man <SEP> zu <SEP> einer
<tb> Vetbind,ung <SEP> von <SEP> Isopropyla.llylibarbitursäure
<tb> mit <SEP> 1-Phenyl-?,3-,drimethyl=4-,dimethylamino 5-pyrazolongelangen <SEP> kann:, <SEP> wenn. <SEP> man <SEP> mole kulare <SEP> Mengen <SEP> eines <SEP> Salzes <SEP> der <SEP> Iso:propyl allylbar@bitursäure <SEP> und <SEP> eines <SEP> .Salzes <SEP> :des <SEP> 1 Phenyl-2,3-,di:methyl- <SEP> 4 <SEP> -idim,ethylia,mino-5-py razolons <SEP> in <SEP> einem <SEP> Lösungsmittel <SEP> aufeinander
<tb> einwirken <SEP> lässt.
<tb>
Zur <SEP> Ausführung <SEP> dieser <SEP> doppelten <SEP> Um setzung <SEP> .hat <SEP> sich <SEP> eine <SEP> aesättIgte <SEP> wässerige
<tb> Lösung <SEP> von <SEP> 1 <SEP> - <SEP> Phenyl <SEP> - <SEP> ?,3 <SEP> -,dimethyl <SEP> - <SEP> 4 <SEP> - <SEP> di methylamin.o-5-pyrazolon <SEP> als <SEP> Lösungsmittel
<tb> be:3onders <SEP> bewährt.
<tb>
Auf <SEP> diesem <SEP> Wege <SEP> wird <SEP> die <SEP> Verbindung
<tb> in <SEP> völlig <SEP> farblosen <SEP> Kristallnadeln <SEP> vorn
<tb> Schmelzpunkt <SEP> 97 <SEP> <SEP> erhalten; <SEP> sie <SEP> enthält
<tb> weder <SEP> den <SEP> basischen <SEP> Rest <SEP> :des <SEP> hanbitursauren
<tb> Salzes, <SEP> noch <SEP> den <SEP> sauren <SEP> Rest <SEP> ides <SEP> Pyrazolon sal@zes.
<tb>
Die <SEP> neue <SEP> Verbindung <SEP> ist <SEP> in <SEP> Alkohol, <SEP> Me thy <SEP> la,lkohol <SEP> und <SEP> Äther <SEP> leicht, <SEP> in <SEP> Wasser
<tb> >zchwer <SEP> löslich. <SEP> Sie <SEP> besitzt <SEP> gleichzeitig <SEP> hyp- notische und anal,getische Eigenschaften und soll in der Therapie verwendiet werden.
EMI0001.0008
<I>Beispiel:</I>
EMI0001.0009
232 <SEP> Teile <SEP> iso(propyl:a.1157lb@arbiturs:aure!s <SEP> N:a triu.m <SEP> werden <SEP> in <SEP> ider <SEP> eben <SEP> hinreichenden
<tb> Menge <SEP> einer <SEP> igesättigten, <SEP> wässerigen <SEP> Lösung
<tb> von <SEP> 1-Phenyl-2,3-@dim-ethyl-4-idim.ethyla@mino 5-pirazolon <SEP> gelöst <SEP> und <SEP> unter <SEP> Turbinieren
<tb> langsam <SEP> mit <SEP> einer <SEP> Lösung <SEP> von <SEP> 268 <SEP> Teilen
<tb> 1-Phenyi-2,3-:
dimethyl-4-,dmethyl- <SEP> 5 <SEP> -pyrazo lon <SEP> in <SEP> 1000 <SEP> Teilen <SEP> einer <SEP> mit <SEP> ,dem <SEP> gleichen
<tb> Py <SEP> razolonderivat <SEP> gesättigten, <SEP> normalen <SEP> Salz säure <SEP> vereinigt. <SEP> Das <SEP> Reaktionsprodukt <SEP> schei det <SEP> sich <SEP> als <SEP> völlig <SEP> farbloses <SEP> 01 <SEP> ab, <SEP> .das <SEP> nach
<tb> einiger <SEP> Zeit <SEP> zu <SEP> Kristallnadeln <SEP> vom <SEP> Schmelz punkt <SEP> <B>97</B> <SEP> <SEP> C <SEP> erstarrt.
Process for the preparation of a compound of isopropylallylbarbituric acid with 1-phenyl-2,3-dimethyl-4-dimethylamino-6-pyrazolone.
EMI0001.0003
<SEP> was found <SEP> @ d @ en, <SEP>: that '<SEP> man <SEP> to <SEP> one
<tb> Vetbind, ung <SEP> from <SEP> Isopropyla.llylibarbituric acid
<tb> with <SEP> 1-phenyl - ?, 3-, drimethyl = 4-, dimethylamino 5-pyrazolone can get <SEP> :, <SEP> if. <SEP> man <SEP> molecular <SEP> amounts of <SEP> of a <SEP> salt <SEP> of <SEP> iso: propyl allylbar @ bituric acid <SEP> and <SEP> of a <SEP> salt <SEP> : des <SEP> 1 phenyl-2,3-, di: methyl- <SEP> 4 <SEP> -idim, ethylia, mino-5-py razolons <SEP> in <SEP> a <SEP> solvent <SEP> on each other
<tb> allows <SEP> to take effect.
<tb>
For the <SEP> execution <SEP> of this <SEP> double <SEP> implementation <SEP>. <SEP> has <SEP> an <SEP> saturated <SEP> aqueous
<tb> Solution <SEP> of <SEP> 1 <SEP> - <SEP> Phenyl <SEP> - <SEP>?, 3 <SEP> -, dimethyl <SEP> - <SEP> 4 <SEP> - <SEP > di methylamin.o-5-pyrazolon <SEP> as <SEP> solvent
<tb> be: 3onders <SEP> proven.
<tb>
On <SEP> this <SEP> path <SEP>, <SEP> becomes the <SEP> connection
<tb> in <SEP> completely <SEP> colorless <SEP> crystal needles <SEP> in front
<tb> Melting point <SEP> 97 <SEP> <SEP> obtained; <SEP> it contains <SEP>
<tb> neither <SEP> the <SEP> basic <SEP> rest <SEP>: of the <SEP> hanbituric acid
<tb> salt, <SEP> nor <SEP> the <SEP> acidic <SEP> rest <SEP> ides <SEP> pyrazolone sal @ zes.
<tb>
The <SEP> new <SEP> compound <SEP> is <SEP> in <SEP> alcohol, <SEP> Me thy <SEP> la, lkohol <SEP> and <SEP> ether <SEP> light, <SEP> in <SEP> water
<tb>> difficult <SEP> soluble. <SEP> She <SEP> has <SEP> at the same time <SEP> hypnotic and anal, getic properties and should be used in therapy.
EMI0001.0008
<I> Example: </I>
EMI0001.0009
232 <SEP> parts <SEP> iso (propyl: a.1157lb@arbiturs: aure! S <SEP> N: a triu.m <SEP> are <SEP> in <SEP> ider <SEP> just <SEP> sufficient
<tb> Amount of <SEP> of a <SEP> unsaturated, <SEP> aqueous <SEP> solution
<tb> dissolved from <SEP> 1-phenyl-2,3- @ dim-ethyl-4-idim.ethyla @ mino 5-pirazolon <SEP> <SEP> and <SEP> under <SEP> turbine
<tb> slowly <SEP> with <SEP> a <SEP> solution <SEP> of <SEP> 268 <SEP> parts
<tb> 1-Phenyi-2,3-:
dimethyl-4-, dmethyl- <SEP> 5 <SEP> -pyrazo lon <SEP> in <SEP> 1000 <SEP> parts <SEP> one <SEP> with <SEP>, the <SEP> same
<tb> Py <SEP> razolone derivative <SEP> saturated, <SEP> normal <SEP> hydrochloric acid <SEP> combined. <SEP> The <SEP> reaction product <SEP> separates <SEP> from <SEP> as <SEP> completely <SEP> colorless <SEP> 01 <SEP>, <SEP> .the <SEP>
<tb> some <SEP> time <SEP> to <SEP> crystal needles <SEP> from <SEP> melting point <SEP> <B> 97 </B> <SEP> <SEP> C <SEP> solidified.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH141804T | 1929-03-02 | ||
| CH131927T | 1929-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH141804A true CH141804A (en) | 1930-08-15 |
Family
ID=25711719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH141804D CH141804A (en) | 1929-03-02 | 1929-03-02 | Process for the preparation of a compound of isopropylallylbarbituric acid with 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH141804A (en) |
-
1929
- 1929-03-02 CH CH141804D patent/CH141804A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH141804A (en) | Process for the preparation of a compound of isopropylallylbarbituric acid with 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. | |
| CH135405A (en) | Process for the preparation of a compound of n-butylallylbarbituric acid and 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. | |
| CH141803A (en) | Process for the preparation of a compound of diethyl barbituric acid with 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. | |
| CH141805A (en) | Process for the preparation of a compound of phenylethylbarbituric acid with 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. | |
| DE536274C (en) | Process for the preparation of double compounds of phenylaethylbarbituric acid | |
| CH135403A (en) | Process for the preparation of a compound of diallyl barbituric acid and 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. | |
| DE633786C (en) | Process for the preparation of complex compounds of 1,3-dimethylxanthine | |
| CH135404A (en) | Process for the preparation of a compound of n-propylallylbarbituric acid and 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. | |
| DE937373C (en) | Process for the production of aqueous pharmaceutical solutions | |
| DE227013C (en) | ||
| DE357751C (en) | Process for the preparation of a derivative of 4-dimethylamino-1-phenyl-2,3-dimethyl-5-pyrazolone which is readily soluble in water | |
| DE552922C (en) | Process for the preparation of a salt of 2,4-diaminoazobenzene | |
| DE495336C (en) | Process for the preparation of basic oxime ethers and their salts | |
| DE303450C (en) | ||
| AT117213B (en) | Process for the preparation of poorly soluble salts of organic bases and of alkaloids. | |
| CH194681A (en) | Process for the preparation of sulfanilic acid-4-aminoanilide. | |
| CH139407A (en) | Process for the preparation of 3,6-diamino-10-methylacridinium deoxycholate. | |
| CH186672A (en) | Process for the preparation of a diuretically effective preparation suitable for rectal use. | |
| CH135160A (en) | Process for preparing a compound of -1,2-cyclohexenyl-ethylbarbituric acid and 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. | |
| CH158448A (en) | Process for the preparation of the hydroiodic acid carbaminoycholine. | |
| CH162292A (en) | Process for the preparation of the salt of 2. 3-Dimethoxy-6-nitro-9- (γ-diethylamino-B-oxypropylamino) acridine with p-glycolylaminobenzenic acid. | |
| CH181733A (en) | Process for the preparation of a compound of 1-phenyl-2,3-dimethyl-4-isopropyl-5-pyrazolone with B-bromoallyl-isopropylbarbituric acid. | |
| CH169578A (en) | Process for the preparation of the salt of 2,3-dimethoxy-6-nitro-9- (Y-diethylamino-B-oxy-propylamino) -acridine with p-glycolylaminobenzolaric acid. | |
| CH161242A (en) | Process for the preparation of the acetic acid ester of 4-lactylaminobenzene-1-arsic acid. | |
| CH126680A (en) | Process for the preparation of a compound of quinine and isobutylallylbarbituric acid. |